STOCK TITAN

[Form 4] Enovis Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Enovis insider purchase disclosed on Form 4. Philip Benjamin Berry, SVP and Chief Financial Officer, purchased 2,500 shares of Enovis Corporation (ticker ENOV) on 08/20/2025 at a price of $29.71 per share. After the transaction, Mr. Berry beneficially owned 116,729 shares. The Form 4 was filed as a single reporting person filing and was signed by attorney-in-fact Brian P. Hanigan on 08/20/2025.

Operazione interna Enovis riportata nel Form 4. Philip Benjamin Berry, Vicepresidente Senior e Chief Financial Officer, ha acquistato 2.500 azioni di Enovis Corporation (ticker ENOV) il 20/08/2025 al prezzo di $29,71 per azione. Dopo l’operazione, il signor Berry deteneva beneficiariamente 116.729 azioni. Il Form 4 è stato presentato come dichiarazione di una sola persona segnalante ed è stato firmato per procura dall’avvocato Brian P. Hanigan il 20/08/2025.

Compra interna de Enovis divulgada en el Form 4. Philip Benjamin Berry, vicepresidente senior y director financiero, adquirió 2.500 acciones de Enovis Corporation (símbolo ENOV) el 20/08/2025 a $29,71 por acción. Tras la transacción, el Sr. Berry poseía de forma beneficiaria 116.729 acciones. El Form 4 se presentó como una declaración de una sola persona informante y fue firmado por apoderado, el abogado Brian P. Hanigan, el 20/08/2025.

Form 4에 공시된 Enovis 내부자 매수. Philip Benjamin Berry 수석부사장 겸 최고재무책임자(CFO)가 2025-08-20에 Enovis Corporation(티커 ENOV) 주식 2,500주를 주당 $29.71에 매수했습니다. 거래 후 Berry 씨는 실질적으로 116,729주를 보유하게 되었습니다. 해당 Form 4는 단일 보고자 신고로 제출되었으며, 2025-08-20에 법정대리인(Attorney-in-fact) Brian P. Hanigan이 서명했습니다.

Achat interne d’Enovis déclaré sur le Form 4. Philip Benjamin Berry, vice-président principal et directeur financier, a acheté 2 500 actions d’Enovis Corporation (symbole ENOV) le 20/08/2025 au prix de 29,71 $ par action. Après la transaction, M. Berry détenait à titre bénéficiaire 116 729 actions. Le Form 4 a été déposé comme déclaration d’une seule personne déclarante et a été signé par mandataire, l’avocat Brian P. Hanigan, le 20/08/2025.

Enovis Insider-Kauf im Formular 4 offengelegt. Philip Benjamin Berry, Senior Vice President und Chief Financial Officer, erwarb am 20.08.2025 2.500 Aktien der Enovis Corporation (Ticker ENOV) zum Preis von $29,71 je Aktie. Nach der Transaktion besaß Herr Berry wirtschaftlich 116.729 Aktien. Das Formular 4 wurde als Einzelmeldung eingereicht und am 20.08.2025 vom bevollmächtigten Rechtsanwalt Brian P. Hanigan unterschrieben.

Positive
  • Reporting person acquired 2,500 shares of Enovis Corporation on 08/20/2025.
  • Transaction price is documented as $29.71 per share.
  • Form 4 shows beneficial ownership of 116,729 shares after the transaction.
  • Form was executed and dated by an attorney-in-fact (Brian P. Hanigan) on 08/20/2025.
Negative
  • None.

Insights

TL;DR: Officer purchase of 2,500 shares at $29.71 increases insider ownership to 116,729 shares; routine Form 4 disclosure.

The filing documents a non-derivative acquisition by Philip Benjamin Berry, the company's SVP and CFO, of 2,500 common shares on 08/20/2025 at $29.71 per share. The report shows beneficial ownership of 116,729 shares following the purchase. The disclosure follows standard Section 16 reporting requirements and was executed by an attorney-in-fact.

TL;DR: Proper Section 16 Form 4 filed for an insider purchase; signature by attorney-in-fact is documented.

The Form 4 identifies the reporting person as an officer (SVP, Chief Financial Officer) and records a purchase transaction coded as "P." The filing indicates it was submitted by one reporting person and includes a manual signature line executed by the attorney-in-fact, Brian P. Hanigan, dated 08/20/2025, consistent with procedural requirements for Form 4 disclosures.

Operazione interna Enovis riportata nel Form 4. Philip Benjamin Berry, Vicepresidente Senior e Chief Financial Officer, ha acquistato 2.500 azioni di Enovis Corporation (ticker ENOV) il 20/08/2025 al prezzo di $29,71 per azione. Dopo l’operazione, il signor Berry deteneva beneficiariamente 116.729 azioni. Il Form 4 è stato presentato come dichiarazione di una sola persona segnalante ed è stato firmato per procura dall’avvocato Brian P. Hanigan il 20/08/2025.

Compra interna de Enovis divulgada en el Form 4. Philip Benjamin Berry, vicepresidente senior y director financiero, adquirió 2.500 acciones de Enovis Corporation (símbolo ENOV) el 20/08/2025 a $29,71 por acción. Tras la transacción, el Sr. Berry poseía de forma beneficiaria 116.729 acciones. El Form 4 se presentó como una declaración de una sola persona informante y fue firmado por apoderado, el abogado Brian P. Hanigan, el 20/08/2025.

Form 4에 공시된 Enovis 내부자 매수. Philip Benjamin Berry 수석부사장 겸 최고재무책임자(CFO)가 2025-08-20에 Enovis Corporation(티커 ENOV) 주식 2,500주를 주당 $29.71에 매수했습니다. 거래 후 Berry 씨는 실질적으로 116,729주를 보유하게 되었습니다. 해당 Form 4는 단일 보고자 신고로 제출되었으며, 2025-08-20에 법정대리인(Attorney-in-fact) Brian P. Hanigan이 서명했습니다.

Achat interne d’Enovis déclaré sur le Form 4. Philip Benjamin Berry, vice-président principal et directeur financier, a acheté 2 500 actions d’Enovis Corporation (symbole ENOV) le 20/08/2025 au prix de 29,71 $ par action. Après la transaction, M. Berry détenait à titre bénéficiaire 116 729 actions. Le Form 4 a été déposé comme déclaration d’une seule personne déclarante et a été signé par mandataire, l’avocat Brian P. Hanigan, le 20/08/2025.

Enovis Insider-Kauf im Formular 4 offengelegt. Philip Benjamin Berry, Senior Vice President und Chief Financial Officer, erwarb am 20.08.2025 2.500 Aktien der Enovis Corporation (Ticker ENOV) zum Preis von $29,71 je Aktie. Nach der Transaktion besaß Herr Berry wirtschaftlich 116.729 Aktien. Das Formular 4 wurde als Einzelmeldung eingereicht und am 20.08.2025 vom bevollmächtigten Rechtsanwalt Brian P. Hanigan unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BERRY PHILLIP BENJAMIN (BEN)

(Last) (First) (Middle)
2711 CENTERVILLE ROAD
SUITE 400

(Street)
WILMINGTON DE 19808

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Enovis CORP [ ENOV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.001 08/20/2025 P 2,500 A $29.71 116,729 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Brian P. Hanigan, attorney-in-fact 08/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did the Enovis (ENOV) Form 4 report?

The Form 4 reports that Philip Benjamin Berry purchased 2,500 shares of Enovis common stock on 08/20/2025.

At what price were the Enovis shares bought on the Form 4?

The reported purchase price was $29.71 per share.

How many Enovis shares does the reporting person own after the transaction?

After the reported transaction the filing shows beneficial ownership of 116,729 shares.

Who is the reporting person on the Form 4 for ENOV?

The reporting person is Philip Benjamin Berry, listed as SVP, Chief Financial Officer.

When was the Form 4 signed and by whom?

The Form 4 signature was made by attorney-in-fact Brian P. Hanigan and dated 08/20/2025.
Enovis Corp

NYSE:ENOV

ENOV Rankings

ENOV Latest News

ENOV Latest SEC Filings

ENOV Stock Data

1.80B
56.26M
1.56%
121.27%
12.03%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WILMINGTON